Avenna Admin

Avenna at SEHTA Conference

In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease.

Avenna at NOAH Conference

In our presentation at this renowned tech conference, our CEO discusses the burden of chronic inflammatory diseases (CIDs) and limitations in CIDs diagnostic procedures. . Additionally, this presentation explains how Avenna medical technology aims to reliably detect and predict future CIDs using molecular signals from blood samples.

Avenna Technology and Products

This video introduces our technology and products we are developing. We explain how our product and services can help enhance how healthcare is performed for chronic and acute inflammatory diseases. We also expand on how our tests can help extend the healthspan of an individual.

https://www.linkedin.com/posts/avenna-ltd_glycans-are-crucial-in-covid-19-infection-activity-6785481637766414336-4xrj

Introduction to Avenna

In this video, we explain how Avenna’s innovative personalised precision medicine technology, GlyHealth can help to overcome current limitations faced in the healthcare sector. We also talk about the varieties of our solutions available to different members of the healthcare ecosystem, including Biopharmaceutical companies.